Enveric Biosciences (ENVB) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Enveric Biosciences (ENVB) is Moderate Underperform.

The composite score behind that read is -0.36, weighing +0.00 of bullish evidence against -0.66 bearish.

Enveric Biosciences last closed at $1.45, -4.61% on the session.

Against the IVW growth benchmark the position is -5.41% over the forecast window.

The read is built from 15 underlying insights — 0 bullish and 15 bearish.

Agreement across those insights is 100%.

20 graded predictions for ENVB so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Enveric Biosciences in the 6th percentile on return on equity, where 100 is best.

Enveric Biosciences is classified under Health Care / Pharmaceuticals, with a market capitalisation of $6.80M.

StockMap tracks Enveric Biosciences as the 134th largest of the 151 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 90 Neutral, 46 Moderate Underperform and 15 Moderate Outperform.

On that composite Enveric Biosciences ranks 139th of 151 in the group, against a group median of -0.08.